Precigen
PGEN
#4518
Rank
โ‚น251.34 B
Marketcap
โ‚น705.02
Share price
3.07%
Change (1 day)
102.20%
Change (1 year)

Earnings for Precigen (PGEN)

Earnings in 2026 (TTM): -โ‚น18.14 Billion

According to Precigen's latest financial reports the company's current earnings are โ‚น31.59 Million. In 2025 the company made an earning of -โ‚น23.92 Billion a decrease over its 2024 earnings that were of -โ‚น12.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Precigen from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น18.14 Billion-24.15%
2025 -โ‚น23.92 Billion95.77%
2024 -โ‚น12.22 Billion32.86%
2023 -โ‚น9.2 Billion20.5%
2022 -โ‚น7.63 Billion-23.33%
2021 -โ‚น9.96 Billion60.11%
2020 -โ‚น6.22 Billion-65.1%
2019 -โ‚น17.81 Billion-65.19%
2018 -โ‚น51.16 Billion313.44%
2017 -โ‚น12.38 Billion-33.2%
2016 -โ‚น18.53 Billion123.22%
2015 -โ‚น8.3 Billion1.47%
2014 -โ‚น8.18 Billion109.54%
2013 -โ‚น3.91 Billion-50.04%
2012 -โ‚น7.82 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Organovo
ONVO
-โ‚น0.24 Billion-98.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
-โ‚น6.98 Billion-64.26%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
-โ‚น6.15 Billion-68.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
-โ‚น14.2 Billion-27.22% Jersey